C. Zamagni

发表论文 377 篇 · 总被引 6559 次 · h-index 40

代表论文

• Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study. (2026 · The Lancet · 被引 36)
• LBA39 Final overall survival (OS) results from the randomized double-blind phase III AtTEnd/ENGOT-EN7 trial evaluating atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer (2025 · Annals of Oncology · 被引 6)
• Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia: Trichoscopy, Reflectance Confocal Microscopy and Histopathology Study on 77 Patients (2025 · Dermatologic Therapy · 被引 5)
• Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype (2025 · Histopathology · 被引 3)
• Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus (2026 · Breast · 被引 2)
• Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial (2026 · Clinical Cancer Research · 被引 2)